Wellcome Centre for Infectious Disease Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, United States.
Front Immunol. 2022 Nov 11;13:1009016. doi: 10.3389/fimmu.2022.1009016. eCollection 2022.
Studies of the immune response at the site of disease in extra-pulmonary tuberculosis (EPTB) disease are scarce. In this study, we compared the cellular profile of (Mtb)-specific T cells in pericardial fluid and peripheral blood in patients with pericardial TB (PCTB). Whole blood and pericardial fluid (PCF) samples were collected at the time of diagnostic sampling, with repeat blood sampling after completion of anti-tubercular treatment (ATT) in 16 PCTB patients, most of them being HIV-1 infected (n=14). These samples were stimulated and the phenotypic and functional cellular profile of PCF and blood was assessed by flow cytometry. We found that lymphocytes were the predominant cell type in PCF in PCTB, with a preferential influx of CD4 T cells. The frequencies of TNF-α producing Mtb-specific granulocytes and Mtb-specific CD4 T cells were significantly higher in PCF compared to blood. Mtb-specific CD4 T cells in PCF exhibited a distinct phenotype compared to those in blood, with greater GrB expression and lower CD27 and KLRG1 expression. We observed no difference in the production IFNγ, TNF or IL-2 by Mtb-specific CD4 T cells between the two compartments, but MIP-1β production was lower in the PCF T cells. Bacterial loads were not associated with alterations in the phenotype or function of Mtb-specific CD4 T cells. Upon ATT completion, HLA-DR, Ki-67 and GrB expression was significantly decreased, and relative IL-2 production was increased in peripheral Mtb-specific CD4 T cells. Overall, using an assay to compare the immune response towards Mtb in PCF and in blood, we identified significant difference in the phenotypic profile of Mtb-specific CD4 T response between these two compartments. Moreover, we show that the activation profile of peripheral Mtb-specific CD4 T cells could be used to monitor treatment response in PCTB.
在肺外结核(EPTB)疾病中,对疾病部位免疫反应的研究很少。在这项研究中,我们比较了心包结核(PCTB)患者心包液和外周血中(Mtb)特异性 T 细胞的细胞表型。在 16 名 PCTB 患者的诊断性取样时采集全血和心包液(PCF)样本,并在完成抗结核治疗(ATT)后重复采血,其中大多数患者感染了 HIV-1(n=14)。这些样本被刺激,通过流式细胞术评估 PCF 和血液的表型和功能细胞特征。我们发现,淋巴细胞是 PCTB 中 PCF 的主要细胞类型,CD4 T 细胞优先流入。与血液相比,PCF 中产生 TNF-α的 Mtb 特异性粒细胞和 Mtb 特异性 CD4 T 细胞的频率显著更高。与血液中的 Mtb 特异性 CD4 T 细胞相比,PCF 中的 Mtb 特异性 CD4 T 细胞表现出明显不同的表型,具有更高的 GrB 表达和更低的 CD27 和 KLRG1 表达。我们观察到,在两个隔室中,Mtb 特异性 CD4 T 细胞产生 IFNγ、TNF 或 IL-2 没有差异,但 PCF T 细胞中 MIP-1β的产生较低。细菌负荷与 Mtb 特异性 CD4 T 细胞表型或功能的改变无关。ATT 完成后,外周血 Mtb 特异性 CD4 T 细胞中 HLA-DR、Ki-67 和 GrB 的表达显著降低,相对 IL-2 的产生增加。总体而言,我们使用 分析来比较 PCF 和血液中针对 Mtb 的免疫反应,我们确定了这两个隔室中 Mtb 特异性 CD4 T 反应的表型特征存在显著差异。此外,我们表明外周血 Mtb 特异性 CD4 T 细胞的激活谱可用于监测 PCTB 的治疗反应。